Hap Trading, LLC Bio Cardia, Inc. Put Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$17.7 - $32.55 $201,780 - $371,069	-11,400 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$21.3 - $39.0 $242,820 - $444,600	11,400 New	11,400 $15,000
Q4 2021 Feb 14, 2022	SELL	$25.65 - $46.05 $292,410 - $524,970	-11,400 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$42.6 - $58.65 $485,640 - $668,610	11,400 New	11,400 $14,000
Q2 2021 Aug 11, 2021	SELL	$48.9 - $74.85 $611,250 - $935,624	-12,500 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$51.3 - $78.15 $641,250 - $976,875	12,500 New	12,500 $14,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $41.2M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.